Sichuan Colon Pharmaceutical News and Activities

Sichuan Colon Pharmaceutical is one of the...

• CSI 300;
• TOB Iconic 10,000.

Sichuan Colon Pharmaceutical is a company listed under the stock ticker 002422 (CN).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 22 main executives

Most searched biographies at Sichuan Colon Pharmaceutical

• Sichuan Liu, General Manager, Director
• Xianxiang Zhou, Director
• Fuqing Wang, Independent Director

Create your alert
to follow the executive moves at Sichuan Colon Pharmaceutical.

Sichuan Colon Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Sichuan Colon Pharmaceutical

Social media about Sichuan Colon Pharmaceutical

• Sichuan Colon Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Sichuan Colon Pharmaceutical on LinkedIn, X (Twitter) & YouTube